Stereotactic Body Radiotherapy for Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of a Phase I Dose-Escalation Trial

Article ID	Journal	Published Year	Pages	File Type
8234288	International Journal of Radiation OncologyBiologyPhysics	2009	8 Pages	PDF

Abstract

Reirradiation up to 44 Gy using SBRT is well tolerated in the acute setting and warrants further evaluation in combination with conventional and targeted therapies.

Keywords

PET-CT Stereotactic body radiotherapy Reirradiation Head-and-neck cancer head-and-neck squamous cell carcinoma

Related Topics

Physical Sciences and Engineering Physics and Astronomy Radiation

Preview

Stereotactic Body Radiotherapy for Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of a Phase I Dose-Escalation Trial

Authors

Dwight E. M.D., F.A.C.R.O., Robert L. M.D., Ph.D., Michalis M.D., Regiane S. M.D., Erin L. B.S., Steven M.D., William E. M.S., Barton F. M.D., James M. M.D., Ph.D., Jonas T. M.D., Athanassios M.D., Jennifer R. M.D., Stephen Y. M.D., Ph.D.,